Table 2.
Minimum Inhibitory Concentration (µg/ml) of AgNCs
| C + * | Minimal inhibitory concentrations (µg/ml) | ||||
|---|---|---|---|---|---|
| W-del-AgNC | M-del-AgNC | W-ac-AgNC | M-ac-AgNC | ||
| E coli ATCC 8739 | 8.00 | 12.5 | 12.5 | 6 | 12.5 |
| Staph aureus MRSA ATCC 43300 | ND | 12.5 | 25 | 6 | 12.5 |
| Clostridium perfringens ATCC 13124 | 5.00 | 6 | 12.5 | 6 | 3 |
| Bacillus cereus ATCC 10876 | 2.00 | 3 | 6.00 | 3 | 1.5 |
*C + : Gentamycin, Whey-del-AgNCs: Synthesized using Lb delbrueckii grown in whey medium with an initial concentration of 4 mmol AgNO3, MRS-del-AgNCs: Synthesized using Lb delbrueckii grown in MRS broth medium with an initial concentration of 4 mmol AgNO3. Whey-ac-AgNCs: Synthesized using Lb acidophilus grown in whey medium with an initial concentration of 4 mmol AgNO3, MRS-ac-AgNCs: Synthesized using L. acidophilus grown in MRS broth medium with an initial concentration of 4 mmol AgNO3